Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients

Journal of Clinical Microbiology

Volumn 49, Issue 2, 2011, Pages 534-538

  Yu, Jigui ^a   Salamon, Douglas ^b   Marcon, Mario ^b,c   Nahm, Moon H ^a  

^a University of Alabama at Birmingham   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE;

ADOLESCENT; ARTICLE; BACTERIAL MEMBRANE; CHILD; CLINICAL ARTICLE; GENE LOCUS; HUMAN; IMMUNOASSAY; INFANT; NONHUMAN; PEDIATRICS; PLEURA EFFUSION; PLEURA FLUID; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOASSAY; INFANT; PLEURAL EFFUSION; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 79951473317     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01827-10     Document Type: Article

References (31)

1. Aguiar, S. I., M. J. Brito, J. Goncalo-Marques, J. Melo-Cristino, and M. Ramirez. 2010. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use. Vaccine 28:5167-5173.
2. Avci, F. Y., and D. L. Kasper. 2010. How bacterial carbohydrates influence the adaptive immune system. Annu. Rev. Immunol. 28:107-130.
3. Bekri, H., et al. 2007. Streptococcus pneumoniae serotypes involved in children with pleural empyemas in France. Arch. Pediatr. 14:239-243.
4. Bratcher, P. E., K. H. Kim, J. H. Kang, J. Y. Hong, and M. H. Nahm. 2010. Identification of natural pneumococcal isolates expressing serotype 6D by genetic, biochemical, and serological characterization. Microbiology 156:555-560.
5. Burton, R. L., and M. H. Nahm. 2006. Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies. Clin. Vaccine Immunol. 13:1004-1009.
6. Byington, C. L., et al. 2010. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J. Clin. Microbiol. 48:520-525.
7. Byington, C. L., et al. 2006. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr. Infect. Dis. J. 25:250-254.
8. Cobb, B. A., and D. L. Kasper. 2005. Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens. Cell. Microbiol. 7:1398-1403.
9. Doskeland, S. O., and B. P. Berdal. 1980. Bacterial antigen detection in body fluids: methods for rapid antigen concentration and reduction of nonspecific reactions. J. Clin. Microbiol. 11:380-384.
10. Eastham, K. M., et al. 2004. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 59:522-525. (Pubitemid 38797527)
11. Finland, M., and M. W. Barnes. 1977. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J. Clin. Microbiol. 5:154-166.
12. Fletcher, M., J. Leeming, K. Cartwright, and A. Finn. 2006. Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 25:559-560.
13. Goldbart, A. D., et al. 2009. Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine. Scand. J. Infect. Dis. 41:182-187.
14. Hicks, L. A., et al. 2007. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J. Infect. Dis. 196:1346-1354.
15. Hu, B. T., et al. 2005. Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae. Clin. Diagn. Lab. Immunol. 12:287-295.
16. Huang, S. S., et al. 2009. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 124:e1-e11.
17. Langley, J. M., et al. 2008. Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect. Dis. 8:129.
18. Marcon, M. J., D. Salamon, and J. Cuartas. 2009. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother., abstr. D-780.
19. Pai, R., R. E. Gertz, and B. Beall. 2006. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J. Clin. Microbiol. 44:124-131. (Pubitemid 43100590)
20. Requejo, H. I. 2007. Community-acquired pneumonia in the childhood: analysis of the diagnostic methods. Braz. J. Infect. Dis. 11:246-248.
21. Rodgers, G. L., A. Arguedas, R. Cohen, and R. Dagan. 2009. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine 27:3802-3810.
22. Romero-Steiner, S., et al. 2006. Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin. Vaccine Immunol. 13:165-169.
23. Schaffner, A., C. Michel-Harder, and S. Yeginsoy. 1991. Detection of capsular polysaccharide in serum for the diagnosis of pneumococcal pneumonia: clinical and experimental evaluation. J. Infect. Dis. 163:1094-1102.
24. Scott, J. A., et al. 1996. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin. Infect. Dis. 22:973-981.
25. Siegel, J. D., J. C. Gartner, and R. H. Michaels. 1978. Pneumococcal empyema in childhood. Am. J. Dis. Child. 132:1094-1096.
26. Sweeney, J. A., J. S. Sumner, and J. P. Hennessey, Jr. 2000. Simultaneous evaluation of molecular size and antigenic stability of PNEUMOVAX 23, a multivalent pneumococcal polysaccharide vaccine. Dev. Biol. (Basel) 103: 11-26.
27. Tan, T. Q., et al. 2002. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 110:1-6. (Pubitemid 34742634)
28. Tzianabos, A. O., A. B. Onderdonk, B. Rosner, R. L. Cisneros, and D. L. Kasper. 1993. Structural features of polysaccharides that induce intra-abdominal abscesses. Science 262:416-419.
29. Velez, C. D., C. J. Lewis, D. L. Kasper, and B. A. Cobb. 2009. Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II-dependent pathway for antigen presentation. Immunology 127:73-82.
30. Yu, J., M. D. G. Carvalho, B. Beall, and M. H. Nahm. 2008. A rapid pneumococcal serotyping system based on monoclonal antibodies and PCR. J. Med. Microbiol. 57:171-178.
31. Zon, G., S. C. Szu, W. Egan, J. D. Robbins, and J. B. Robbins. 1982. Hydrolytic stability of pneumococcal group 6 (type 6A and 6B) capsular polysaccharides. Infect. Immun. 37:89-103.